LMAT today
$79.30+$0.01 (+0.01%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourLeaning Bullish
15 minBullish
5 minConsolidating
Daily trend turns down below $80.69
Key levels
Resistance$85.81
Resistance$80.69
Support$71.42
Latest news & SEC filings
DealLeMaitre Vascular buys B. Braun vascular product line
AnalystWells Fargo keeps Equal-Weight on LeMaitre Vascular, cuts target to $86
All LMAT news →About LeMaitre Vascular
LeMaitre Vascular makes medical devices and offers cryopreservation services for human tissue, used chiefly in treating conditions of the arteries and veins outside the heart, kidney failure requiring dialysis, and heart conditions. Its offerings include grafts, patches, catheters, shunts, vessel closure systems, valve cutters, and radiopaque tape, sold mainly to vascular surgeons and also to cardiac, general, and neurosurgeons. The company operates across North America, Europe, and Asia, selling mostly through its own sales representatives and through distributors elsewhere.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
LEMAITRE VASCULAR INC (LMAT)
What Is the Price Target for LMAT?
SEPT Low Target
$90.95
SEPT Mid Target
$107.00
SEPT High Target
$123.05
Analyst Consensus
$107.00
Is LMAT a Buy or Sell Right Now?
Thesis
- •Revenue growing 13.5% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LMAT.
Start Free Trial →Is LMAT Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$96.44
60
Moat Score
NARROW
7/9
Piotroski Score
7.0
Altman Z-Score
What Is Smart Money Doing with LMAT?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| LeMaitre George W | director officer | Sale | 11,974 | - | Jun 4, 2026 |
| LeMaitre George W | director officer | Buy | 11,974 | - | Jun 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LMAT Growth Story
Revenue YoY
13.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
30.57%
FCF Growth YoY
100.4%
Revenue Trend
STABLE
Dark Pool Trades for LMAT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LMAT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:25 | $79.29 | 1,187 | $$94K | SELL |
| 15:05:09 | $79.47 | 2,660 | $$211K | SELL |
| 14:42:42 | $80.07 | 1,175 | $$94K | BUY |
| 14:42:42 | $80.07 | 1,000 | $$80K | BUY |
| 21:26:58 | $79.02 | 76,032 | $$6.0M | SELL |
5 dark pool trades shown · $$6.5M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for LEMAITRE VASCULAR INC (LMAT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LMAT — frequently asked questions
What is LMAT stock price today?
LEMAITRE VASCULAR INC (LMAT) is at $79.30, up 0.01% (+$0.01) at the Nov 12, 2026 close.
Why is LMAT stock moving today?
Latest LMAT news — Nov 5, 2026: LeMaitre Vascular buys B. Braun vascular product line · Nov 5, 2026: Wells Fargo keeps Equal-Weight on LeMaitre Vascular, cuts target to $86
What is the LMAT price target?
The average analyst price target for LMAT is $107.00, ranging from $94 to $120, based on 2 analysts. Latest: Wells Fargo maintains on Aug 5, 2026.
What do analysts rate LMAT?
Analyst ratings for LMAT: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did LMAT beat earnings?
LMAT last reported on Aug 4, 2026: EPS $0.74 vs $0.81 expected — a miss of 8.3%.
What is LMAT's P/E ratio?
LMAT trades at a P/E of 31.6.
Does LMAT pay a dividend?
Yes. LMAT's dividend yield is 0.99%.
What are LMAT support and resistance levels?
Support: $71.42. Resistance: $80.69, $85.81, $90.28.
What are insiders doing with LMAT?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on LMAT?
Nov 5, 2026: LeMaitre Vascular buys B. Braun vascular product line · Nov 5, 2026: Wells Fargo keeps Equal-Weight on LeMaitre Vascular, cuts target to $86